
After 25 years in healthcare data, Rhapsody's chief marketing officer has learned to look past the glossy interface and ask the stubborn question underneath: can the systems actually understand one another?
Clay Ritchey is the Chief Executive Officer of Verato, a Tysons, Virginia healthcare technology company whose referential identity matching platform helps hospitals, life science firms and government agencies resolve who is who across fragmented records. A Penn State electrical engineer and Harvard MBA, he has spent more than two decades building and scaling healthcare software businesses, including a turn as CEO of Evariant, which merged with Healthgrades in 2020. He took the helm at Verato in 2021 and has become a frequent voice on why patient matching sits at the center of healthcare's digital transformation.